Last reviewed · How we verify

NCT04078880

Iron Supplementation in Hip/Knee Surgery

Completed NA Last updated 9 May 2023
What this trial tests

NA trial testing Sucrosomial iron plus ascorbic acid in Orthopedic Disorder in 82 participants. Completed in 1 January 2020.

Timeline
4 December 2018
Primary endpoint
16 September 2019
1 January 2020

Quick facts

Lead sponsorI.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment82
Start date4 December 2018
Primary completion16 September 2019
Estimated completion1 January 2020
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio — full company profile →

Who can join

Adults 18 to 80, any sex, with Orthopedic Disorder or Hip Arthropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomized controlled trial to evaluate the efficacy of oral iron supplementation in reducing the prevalence of preoperative anemia in a cohort of 82 patients undergoing elective prosthetic hip or knee surgery.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Oral Supplementation with Sucrosomial Ferric Pyrophosphate Plus L-Ascorbic Acid to Ameliorate the Martial Status: A Randomized Controlled Trial.
    Briguglio M, Hrelia S, Malaguti M, De Vecchi E, et al · · 2020 · cited 19× · PMID 32024027 · DOI 10.3390/nu12020386

Verify or expand the search:

Other recruiting trials for Orthopedic Disorder

Currently open trials in the same condition.

Other I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04078880.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing